Drugs / DTX
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT03914443 | May 2019 → Mar 2025 | esophageal squamous cell carcinoma | National Cancer Center, Japan | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | DTX | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03914443 ↗ |